Collegium Pharmaceutical (COLL) Restructuring Costs (2021 - 2025)
Historic Restructuring Costs for Collegium Pharmaceutical (COLL) over the last 3 years, with Q3 2025 value amounting to $10.9 million.
- Collegium Pharmaceutical's Restructuring Costs rose 3987.94% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.5 million, marking a year-over-year increase of 5089.39%. This contributed to the annual value of $33.7 million for FY2024, which is 426.95% up from last year.
- Latest data reveals that Collegium Pharmaceutical reported Restructuring Costs of $10.9 million as of Q3 2025, which was up 3987.94% from $9.8 million recorded in Q2 2025.
- Collegium Pharmaceutical's 5-year Restructuring Costs high stood at $13.3 million for Q1 2025, and its period low was $4.6 million during Q4 2021.
- Its 3-year average for Restructuring Costs is $9.0 million, with a median of $9.0 million in 2024.
- Examining YoY changes over the last 5 years, Collegium Pharmaceutical's Restructuring Costs showed a top increase of 5411.11% in 2025 and a maximum decrease of 2549.3% in 2025.
- Collegium Pharmaceutical's Restructuring Costs (Quarter) stood at $4.6 million in 2021, then soared by 106.92% to $9.5 million in 2024, then rose by 15.12% to $10.9 million in 2025.
- Its last three reported values are $10.9 million in Q3 2025, $9.8 million for Q2 2025, and $13.3 million during Q1 2025.